首页> 外文期刊>Archives of gynecology and obstetrics. >The effect of methyldopa treatment on uterine, umblical and fetal middle cerebral artery blood flows in preeclamptic patients.
【24h】

The effect of methyldopa treatment on uterine, umblical and fetal middle cerebral artery blood flows in preeclamptic patients.

机译:甲基多巴治疗对先兆子痫患者子宫,脐带和胎儿大脑中动脉血流的影响。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The purpose of this study was to evaluate the efficacy of methyldopa in the treatment of preeclamptic patients. This study was performed on 24 preeclamptic women who were in between 25-36 weeks of gestational age. 24 healthy pregnant women were taken as control group. Before starting treatment, 24 preeclamptic patients were examined with Doppler ultrasound. Pulsatility index, resistance index, systolic/diastolic ratio of uterine, umblical and fetal middle cerebral arteries were measured. Preeclamptic patients were treated with totally 1 g methyldopa per day. After 7 d, patients were reexamined with Doppler ultrasound. The effect of methyldopa on uterine, umblical and fetal middle cerebral artery blood flows were detected. Only one control with Doppler ultrasound was done to the healthy pregnant women. Before methyldopa treatment to the preeclamptic women, pulsatility index (PI), resistance index (RI) and systolic/diastolic ratio (S/D) on uterine and umblical arteries were significantly higher than the control group. However, fetal middle cerebral artery (MCA) values were significantly lower than the control group. When Doppler results of preeclamptic patients before and after the methyldopa treatment were compared, no significant differences in terms of Pulsatility Index, Resistance IndexI and S/D ratio of umblical and fetal middle cerebral arteries were found. However, the results of uterine artery were significantly lower after the treatment in preeclamptic patients. Treatment with methyldopa lowered the uterine artery resistance in preeclamptic patients but did not effect the resistance of umblical and fetal middle cerebral artery.
机译:这项研究的目的是评估甲基多巴在先兆子痫患者中的疗效。这项研究是针对24个处于胎龄25-36周的先兆子痫妇女进行的。 24例健康孕妇作为对照组。在开始治疗之前,对24位先兆子痫患者进行了多普勒超声检查。测量搏动指数,抵抗指数,子宫,脐带和胎儿中脑动脉的收缩/舒张比。子痫前期患者每天接受总计1 g甲基多巴治疗。 7天后,用多普勒超声检查患者。检测了甲基多巴对子宫,脐带和胎儿大脑中动脉血流的影响。对健康孕妇仅进行了多普勒超声检查。在对子痫前期妇女进行甲基多巴治疗之前,子宫和脐动脉的搏动指数(PI),抵抗指数(RI)和收缩/舒张比(S / D)显着高于对照组。但是,胎儿大脑中动脉(MCA)值明显低于对照组。当比较甲基多巴治疗前后先兆子痫患者的多普勒结果时,在脐和胎儿中脑动脉的搏动指数,抵抗指数I和S / D比方面没有发现显着差异。然而,先兆子痫患者在治疗后子宫动脉的结果明显降低。甲基多巴治疗可降低先兆子痫患者的子宫动脉抵抗力,但不会影响脐带和胎儿大脑中动脉的抵抗力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号